Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2024 05:00 ET | Source: Research and Markets

Major Musculoskeletal Pain Markets Forecast to Reach $5.39 Billion by 2034 - Insights on Epidemiology, Pipeline Drugs, Trends, Unmet Needs, Sales, Major Players, and More

Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
May 28, 2024 07:00 ET | Source: Research and Markets

Global Friedreich's Ataxia Market Analysis 2023-2034: A Projected $3.39 Billion Opportunity Featuring Strategic Analysis of Reata Pharma, Pfizer, BioMarin Pharma, Retrotope, Voyager Therapeutics, and More

Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Global Friedreich's Ataxia Market" report has been added to ResearchAndMarkets.com's offering.The global Friedreich's ataxia market accounted for USD...
April 02, 2024 07:18 ET | Source: Research and Markets

Migraine in America: Key Insights into Treatment Awareness & Satisfaction - Exploring HCP Engagement and Migraine Treatment Experiences Among Patients

Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Migraine in America 2023: Key Insights into Treatment Awareness & Satisfaction" report has been added to ResearchAndMarkets.com's offering. In...
January 02, 2024 05:38 ET | Source: Research and Markets

Spasticity Treatment Innovations: GABLOFEN Drug Insight and Market Forecast to 2032 Unveiled

Dublin, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The "GABLOFEN Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry professionals and healthcare...
August 01, 2023 09:28 ET | Source: Research and Markets

Pfizer, Amneal Pharmaceuticals, and Merck & Co. Lead the Global Muscle Relaxant Drugs Market with Innovative Drug Offerings and Strong Market Presence

Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The "Muscle Relaxant Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global muscle relaxant drugs market...
May 16, 2022 07:13 ET | Source: Research and Markets

Global Cerebral Palsy Treatment Market Report to 2030 - Featuring Merz Pharmaceuticals, Pfizer, Bayer and Johnson & Johnson Among Others

Dublin, May 16, 2022 (GLOBE NEWSWIRE) -- The "Cerebral Palsy Treatment Market by Drug Type, Disease Type, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report...
May 10, 2021 05:43 ET | Source: Research and Markets

$81 Billion Worldwide Musculoskeletal Disorders Drugs Industry to 2030 - Featuring Pfizer, Abbott Laboratories and Daiichi Sankyo Among Others

Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Musculoskeletal Disorders Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's...
April 07, 2021 07:33 ET | Source: Research and Markets

Insights on the Krabbe Disease Treatment Global Market to 2027 - Featuring Abbott Laboratories, GlaxoSmithKline and Novartis Among Others

Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Krabbe Disease Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...
December 08, 2020 08:53 ET | Source: Research and Markets

Global Multiple Sclerosis Therapies Report 2020-2025

Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...